IL-22 acts on epithelial cells to mediate their barricade to maintain antimicrobial defense mechanisms in the host by reducing Alcaligenes spp., segmented filamentous bacteria (SFB) in the gut, and declining TH17 cell-mediated colitis [69]. This evidence concerns the gene IL22 and colitis.